TGFβ-PDL1 signaling in neutrophils preserves lung barrier during hyperinflammation

Z Ziyi Li A Andrew Reese Moore (Stanford University, Stanford, California, United States) H Hong Zheng (Center of Nanomaterials for Renewable Energy, State Key Laboratory of Electrical Insulation and Power Equipment, School of Electrical Engineering) J Janmes Karunamurthy (McGill University, Montreal, Quebec, Canada) A Aanya Bhagrath (McGill University, Montreal, Quebec, Canada) J Jiangxue Li D Daniel Young L Leonardo F. Jurado (Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada) K Katalina Couto (McGill University, Montreal, Quebec, Canada) A Amelia Kulle (McGill University, Montreal, Quebec, Canada) H Haley Park (McGill University, Montreal, Quebec, Canada) A Ashley Kwak (McGill University Health Centre, Montreal, Quebec, Canada) V Vaishnav Belur (McGill University, Pierrefonds, Quebec, Canada) S Sebastien Talbot M Maziar Divangahi (McGill University, Montreal, QC, Canada) A Antonio DiGiandomenico (AstraZeneca, Gaithersburg, Maryland, United States) A Angela Rogers T Taylor S Cohen (AstraZeneca, Gaithersburg, Maryland, United States) A Allen Joseph Ehrlicher (McGill University, Montreal, PQ, Canada) J Judith N. Mandl (McGill University, Montreal, Quebec, Canada) J Jing Wang (Hunan Cancer Hospital Changsha China) A Antoine Dufour P Purvesh Khatri (Department of Microbiology and Immunology, Stanford University School of Medicine) A Ajitha Thanabalasuriar (McGill University, Montreal, Quebec, Canada)

Abstract

The hyperinflammatory syndromes in critically ill patients, including trauma, sepsis, and acute lung injury, are characterized by dysregulated neutrophil responses that contribute to tissue damage and poor outcomes. Using murine models of cytokine storm induced by trauma and lung injury, we identified transforming growth factor β (TGFβ) as a central regulator of immune checkpoint in neutrophils. TGFβ signaling modulates neutrophil activation and upregulates the expression of programmed death-ligand 1 (PDL1). Disruption of TGFβ signaling during hyperinflammation restores the migratory capacity of neutrophils but leads to excessive activation, severe pulmonary tissue damage, and increased susceptibility to spontaneous bacterial infection in the lung. Mechanistically, PDL1 expression alters neutrophil behavior within lung capillaries, promoting intravascular clustering and restricting tissue infiltration. Targeted deletion of PDL1 in neutrophils reverses hyperinflammation-induced clustering, restores effective trafficking to infectious foci, and enhances host-protective immune function while limiting pathological neutrophil hyperactivation. These findings define a TGFβ-PDL1 regulatory axis that restrains the pathogenicity of neutrophils during hyperinflammation, revealing a checkpoint mechanism that balances host defense and tissue integrity.

Article Details

Journal Blood
Volume / Issue Vol. 1, Issue 1
Published May 19, 2026
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (24)

Z

Ziyi Li

A

Andrew Reese Moore

Stanford University, Stanford, California, United States

H

Hong Zheng

Center of Nanomaterials for Renewable Energy, State Key Laboratory of Electrical Insulation and Power Equipment, School of Electrical Engineering

J

Janmes Karunamurthy

McGill University, Montreal, Quebec, Canada

A

Aanya Bhagrath

McGill University, Montreal, Quebec, Canada

J

Jiangxue Li

D

Daniel Young

L

Leonardo F. Jurado

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

K

Katalina Couto

McGill University, Montreal, Quebec, Canada

A

Amelia Kulle

McGill University, Montreal, Quebec, Canada

H

Haley Park

McGill University, Montreal, Quebec, Canada

A

Ashley Kwak

McGill University Health Centre, Montreal, Quebec, Canada

V

Vaishnav Belur

McGill University, Pierrefonds, Quebec, Canada

S

Sebastien Talbot

M

Maziar Divangahi

McGill University, Montreal, QC, Canada

A

Antonio DiGiandomenico

AstraZeneca, Gaithersburg, Maryland, United States

A

Angela Rogers

T

Taylor S Cohen

AstraZeneca, Gaithersburg, Maryland, United States

A

Allen Joseph Ehrlicher

McGill University, Montreal, PQ, Canada

J

Judith N. Mandl

McGill University, Montreal, Quebec, Canada

J

Jing Wang

Hunan Cancer Hospital Changsha China

A

Antoine Dufour

P

Purvesh Khatri

Department of Microbiology and Immunology, Stanford University School of Medicine

A

Ajitha Thanabalasuriar

McGill University, Montreal, Quebec, Canada